Concepedia

Siebe Loontiens

SL

Statistics

Publications

11

Citations

410

H-Index

11

Active since

2018

Affiliations

Cancer Research Institute Ghent(Current)

Ghent University

Ghent University Hospital

Harvard Stem Cell Institute

Charité - Universitätsmedizin Berlin

Siebe Loontiens is an author at Cancer Research Institute Ghent specializing in life sciences, oncology, and genetics.

ORCID

Publications per year

2018–2025

11

Publications

11

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets

Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste et al. · Nature Communications · 2018 · 111 citations · Full text

, , +17

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Carolina Nunes, Lisa Depestel, Liselot Mus et al. · Science Advances · 2022 · 48 citations · Full text

, , +17

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia

Saara Laukkanen, Alexandra Veloso, Chuan Yan et al. · Blood · 2022 · 45 citations · Full text

, , +14

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry

Bieke Decaesteker, Amber Louwagie, Siebe Loontiens et al. · Nature Communications · 2023 · 44 citations · Full text

, , +17

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors

Areeba Patel, Kirsten Göbel, Sebastian Ille et al. · Nature Medicine · 2025 · 38 citations · Full text

, , +16

1–5 of 11